Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes

International Journal of Cardiology

Volumn 225, Issue , 2016, Pages 387-391

  Mantovani, Alessandro ^a   Mingolla, Lucia ^a   Rigolon, Riccardo ^a   Pichiri, Isabella ^a   Cavalieri, Valentina ^a   Zoppini, Giacomo ^a   Lippi, Giuseppe ^a   Bonora, Enzo ^a   Targher, Giovanni ^a  

^a University and Azienda Ospedaliera Universitaria Integrata of Verona   (Italy)

Author keywords

Cardiovascular disease; NAFLD; Type 1 diabetes

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; RECANALIZATION; RETROSPECTIVE STUDY; SMOKING; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC IMAGING; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES;

EID: 84991826595     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.10.040     Document Type: Article

References (22)

1. [1] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO), EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64 (2016), 1388–1402.
2. [2] Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L., Wymer, M., Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (2016), 73–84.
3. [3] Non-alcoholic fatty liver disease (NAFLD) study group, dedicated to the memory of Prof. Paola LoriaLonardo, A., Bellentani, S., Argo, C.K., et al. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups. Dig. Liver Dis. 47 (2015), 997–1006.
4. [4] Anstee, Q.M., Targher, G., Day, C.P., Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 330–344.
5. [5] Portillo-Sanchez, P., Bril, F., Maximos, M., et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J. Clin. Endocrinol. Metab. 100 (2015), 2231–2238.
6. [6] Targher, G., Day, C.P., Bonora, E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363 (2010), 1341–1350.
7. [7] Mantovani, A., Ballestri, S., Lonardo, A., Targher, G., Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease. Dig. Dis. Sci. 61 (2016), 1246–1267.
8. [8] Targher, G., Byrne, C.D., Lonardo, A., Zoppini, G., Barbui, C., Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J. Hepatol. 65 (2016), 589–600.
9. [9] Targher, G., Bertolini, L., Padovani, R., et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J. Hepatol. 53 (2010), 713–718.
10. [10] Targher, G., Pichiri, I., Zoppini, G., Trombetta, M., Bonora, E., Increased prevalence of cardiovascular disease in type 1 diabetic patients with nonalcoholic fatty liver disease. J. Endocrinol. Invest. 35 (2012), 535–540.
11. [11] American Diabetes Association, Standards of medical care in diabetes 2016. Diabetes Care 39:Suppl. 1 (2016), S72–S74.
12. [12] Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N., Roth, D., Modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern. Med. 130 (1999), 461–470.
13. [13] Mehta, S.R., Thomas, E.L., Bell, J.D., Johnston, D.G., Taylor-Robinson, S.D., Non-invasive means of measuring hepatic fat content. World J. Gastroenterol. 14 (2008), 3476–3483.
14. [14] Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F.L., Guallar, E., Clark, J.M., Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54 (2011), 1082–1090.
15. [15] Targher, G., Bertolini, L., Padovani, R., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30 (2007), 1212–1218.
16. [16] Targher, G., Bertolini, L., Rodella, S., et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30 (2007), 2119–2121.
17. [17] Targher, G., Mantovani, A., Pichiri, I., et al. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin. Sci. (Lond.) 125 (2013), 301–309.
18. [18] Mantovani, A., Pernigo, M., Bergamini, C., et al. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Metabolism 64 (2015), 879–887.
19. [19] Mantovani, A., Rigamonti, A., Bonapace, S., et al. Non-alcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring. Diabetes Care 39 (2016), 1416–1423.
20. [20] Targher, G., Mantovani, A., Pichiri, I., et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care 37 (2014), 1729–1736.
21. [21] Lonardo, A., Sookoian, A., Pirola, C.J., Targher, G., Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65 (2016), 1136–1150.
22. [22] Del Ben, M., Polimeni, L., Carnevale, R., et al. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol., 14, 2014, 81.